Why should the privilege get 21 cents per share when the market is at 25.5 cents, This will be sold down and shorted hard. Shorters I welcome you to a new dog
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025